{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:07:06Z","timestamp":1747181226080,"version":"3.40.5"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:p>Metastatic skin cutaneous melanoma (MSCM) is the most rapidly progressing\/invasive skin-based malignancy, with median survival rates of about 12 months. It appears that metabolic disorders accelerate disease progression. However, correlations between metabolism-linked genes (MRGs) and prognosis in MSCM are unclear, and potential mechanisms explaining the correlation are unknown. The Cancer Genome Atlas (TCGA) was utilized as a training set to develop a genomic signature based on the differentially expressed MRGs (DE-MRGs) between primary skin cutaneous melanoma (PSCM) and MSCM. The Gene Expression Omnibus (GEO) was utilized as a validation set to verify the effectiveness of genomic signature. In addition, a nomogram was established to predict overall survival based on genomic signature and other clinic-based characteristics. Moreover, this study investigated the correlations between genomic signature and tumor micro-environment (TME). This study established a genomic signature consisting of 3 genes (<jats:italic toggle=\"yes\">CD38, DHRS3<\/jats:italic>, and <jats:italic toggle=\"yes\">TYRP1<\/jats:italic>) and classified MSCM patients into low and high-risk cohorts based on the median risk scores of MSCM cases. It was discovered that cases in the high-risk cohort had significantly lower survival than cases in the low-risk cohort across all sets. Furthermore, a nomogram containing this genomic signature and clinic-based parameters was developed and demonstrated high efficiency in predicting MSCM case survival times. Interestingly, Gene Set Variation Analysis results indicated that the genomic signature was involved in immune-related physiological processes. In addition, this study discovered that risk scoring was negatively correlated with immune-based cellular infiltrations in the TME and critical immune-based checkpoint expression profiles, indicating that favorable prognosis may be influenced in part by immunologically protective micro-environments. A novel 3-genomic signature was found to be reliable for predicting MSCM outcomes and may facilitate personalized immunotherapy.<\/jats:p>","DOI":"10.1097\/md.0000000000038347","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T14:10:43Z","timestamp":1717769443000},"page":"e38347","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma"],"prefix":"10.1097","volume":"103","author":[{"given":"Zhongshun","family":"He","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kunming Medical University School and Hospital of Stomatology, Kunming, China"},{"name":"Yunnan Key Laboratory of Stomatology, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lechun","family":"Lyu","sequence":"additional","affiliation":[{"name":"Technology Transfer Center, Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Long","sequence":"additional","affiliation":[{"name":"Yunnan Bestai Biotechnology Co., Ltd., Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0198-9409","authenticated-orcid":false,"given":"Biao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kunming Medical University School and Hospital of Stomatology, Kunming, China"},{"name":"Yunnan Key Laboratory of Stomatology, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2015.07.006","article-title":"Skin cancer.","volume":"42","author":"Linares","year":"2015","journal-title":"Prim Care"},{"key":"R2-20250503","first-page":"223","article-title":"Preview of Hawaii cancer facts and figures 2010.","volume":"69","author":"Hernandez","year":"2010","journal-title":"Hawaii Med J"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy.","volume":"445","author":"Gray-Schopfer","year":"2007","journal-title":"Nature"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00441-007-0530-3","article-title":"microRNA and stem cell function.","volume":"331","author":"Hatfield","year":"2008","journal-title":"Cell Tissue Res"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1586\/era.09.25","article-title":"Current systemic therapy for metastatic melanoma.","volume":"9","author":"Agarwala","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation.","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ctrv.2014.06.012","article-title":"Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma.","volume":"40","author":"Mcdermott","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma.","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma.","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer.","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3892\/ijo.2016.3774","article-title":"Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression.","volume":"50","author":"Liu","year":"2017","journal-title":"Int J Oncol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2011-3437","article-title":"Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.","volume":"97","author":"Loriot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.metabol.2014.02.010","article-title":"Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy.","volume":"63","author":"Xu","year":"2014","journal-title":"Metabolism"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.18632\/oncotarget.6879","article-title":"Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/ijo.2015.3091","article-title":"Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.","volume":"47","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer.","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br J Cancer"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer.","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity.","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.7150\/thno.28219","article-title":"Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming.","volume":"8","author":"Tan","year":"2018","journal-title":"Theranostics"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential.","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"e124989","DOI":"10.1172\/jci.insight.124989","article-title":"Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.","volume":"4","author":"Najjar","year":"2019","journal-title":"JCI Insight"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.semcancer.2019.07.016","article-title":"Metabolic flexibility in melanoma: a potential therapeutic target.","volume":"59","author":"Ruocco","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcdb.2019.05.001","article-title":"Targeting metabolic reprogramming in metastatic melanoma: the key role of nicotinamide phosphoribosyltransferase (NAMPT).","volume":"98","author":"Audrito","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphys.2013.00354","article-title":"Acidic tumor microenvironment and pH-sensing G protein-coupled receptors.","volume":"4","author":"Justus","year":"2013","journal-title":"Front Physiol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.3390\/ijms160511055","article-title":"Molecular connections between cancer cell metabolism and the tumor microenvironment.","volume":"16","author":"Justus","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2019.04.004","article-title":"Stress responses in stromal cells and tumor homeostasis.","volume":"200","author":"Vitale","year":"2019","journal-title":"Pharmacol Ther"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments.","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells.","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.","volume":"25","author":"Parry","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fonc.2020.00788","article-title":"The landscape of iron metabolism-related and methylated genes in the prognosis prediction of clear cell renal cell carcinoma.","volume":"10","author":"Mou","year":"2020","journal-title":"Front Oncol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1111\/jcmm.14647","article-title":"Prognostic power of a lipid metabolism gene panel for diffuse gliomas.","volume":"23","author":"Wu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3389\/fonc.2020.01710","article-title":"Prognostic implications of metabolism related gene signature in cutaneous melanoma.","volume":"10","author":"Zeng","year":"2020","journal-title":"Front Oncol"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fonc.2018.00615","article-title":"Development and validation of a 9-gene prognostic signature in patients with multiple myeloma.","volume":"8","author":"Liu","year":"2019","journal-title":"Front Oncol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jmri.26578","article-title":"Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors.","volume":"50","author":"Iima","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"From the cover: gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.18632\/aging.102087","article-title":"Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.","volume":"11","author":"Song","year":"2019","journal-title":"Aging (Milano)"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00262-018-2150-z","article-title":"Quantifying tumor-infiltrating immune cells from transcriptomics data.","volume":"67","author":"Finotello","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"e44310","DOI":"10.7554\/eLife.44310","article-title":"A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.","volume":"8","author":"Guo","year":"2019","journal-title":"eLife"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1002\/cam4.3438","article-title":"Development of an IFN\u03b3 response-related signature for predicting the survival of cutaneous melanoma.","volume":"9","author":"Hu","year":"2020","journal-title":"Cancer Med"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/jhep.2000.7713","article-title":"Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver.","volume":"31","author":"Goldenmason","year":"2000","journal-title":"Hepatology"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2006.08.066","article-title":"Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38.","volume":"349","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38.","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism.","volume":"23","author":"Camachopereira","year":"2016","journal-title":"Cell Metab"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cmet.2016.05.022","article-title":"Why NAD+ declines during aging: it\u2019s destroyed.","volume":"23","author":"Schultz","year":"2016","journal-title":"Cell Metab"},{"key":"R53-20250503","first-page":"12","article-title":"Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis.","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol Lett"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"31797","DOI":"10.18632\/oncotarget.25737","article-title":"Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis.","volume":"9","author":"Baruch","year":"2018","journal-title":"Oncotarget"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"21790","DOI":"10.1074\/jbc.273.34.21790","article-title":"Molecular characterization of a novel short-chain dehydrogenase\/reductase that reduces all-trans-retinal.","volume":"273","author":"Haeseleer","year":"1998","journal-title":"J Biol Chem"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13058-018-1068-x","article-title":"Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.","volume":"20","author":"Merino","year":"2018","journal-title":"Breast Cancer Res"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-07-4372","article-title":"Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.","volume":"14","author":"Oler","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-06-0157","article-title":"Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.","volume":"66","author":"Furuta","year":"2006","journal-title":"Cancer Res"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/bjc.2013.115","article-title":"Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.","volume":"108","author":"Hajj","year":"2013","journal-title":"Br J Cancer"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/bjc.2015.194","article-title":"SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.","volume":"113","author":"Hajj","year":"2015","journal-title":"Br J Cancer"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.coi.2013.02.009","article-title":"Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.","volume":"25","author":"Gajewski","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition.","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: adenosine in tumor microenvironment.","volume":"7","author":"Ohta","year":"2016","journal-title":"Front Immunol"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology.","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol Rev"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"591079","DOI":"10.3389\/fgene.2020.591079","article-title":"Identifying M1 macrophage-related genes through a co-expression network to construct a four-gene risk-scoring model for predicting thyroid cancer prognosis.","volume":"11","author":"Zhuang","year":"2020","journal-title":"Front Genet"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omto.2020.12.003","article-title":"Single-cell RNA-sequencing analyses identify heterogeneity of CD8 + T cell subpopulations and novel therapy targets in melanoma.","volume":"20","author":"Deng","year":"2020","journal-title":"Mol Ther Oncolytics"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:25:21Z","timestamp":1746318321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":66,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038347","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}